This announcement is a separate document:
普利制药：关于无法在法定期限内披露2023年年度报告及2024年第一季度报告暨公司股票及可转换公司债券停牌的公告
Hainan Poly Pharm: Announcement on the inability to disclose the 2023 Annual Report and the 2024 First Quarter Report and the suspension of trading of company stocks and convertible corporate bonds within the statutory period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.